Trial Profile
Efficacy and Safety of Ivermectin and Albendazole Co-administration in School-aged Children and Adults Infected With Trichuris Trichiura: a Multi-country Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 22 Mar 2024
Price :
$35
*
At a glance
- Drugs Albendazole (Primary) ; Ivermectin (Primary)
- Indications Trichuriasis
- Focus Therapeutic Use
- 16 Mar 2021 Status changed from active, no longer recruiting to completed.
- 10 Dec 2020 Status changed from recruiting to active, no longer recruiting.
- 24 Sep 2019 Planned End Date changed from 1 Aug 2019 to 1 Dec 2020.